00-f5 Title and Logo 00-f6
 guide 目录
 siteinfo 公告


参考文献

 第01章
 第02章
 第03章
 第04章
 第05章
 第06章
 第07章
 第08章
 第09章
 第10章
 第11章
 第12章
 第13章
 第14章
 第15章
 第16章
 第17章
 第18章
 第19章
 第20章
 第21章


 

参考文献

第18章

Abashin VM, Yevtushenko GI. Influence of a permanent magnetic field on biological systems. Biofizika 1975; 20: 276-280; and Abashin VM, Yevtushenko GI. A permanent magnetic field and the conduction of an impulse along the nerve. Biofizika 1975; 20: 281-285.

ACR, American College of Radiogy. Kanal E, Barkovich AJ, Bell C, et al. ACR [American College of Radiology] guidance document for safe MR practice. AJR 2007; 188: 1-27. [Guidelines mainly for the United States].

American Academy of Pediatrics, Committee on Drugs. Guidelines for monitoring and management of pediatric patients during and after sedation for diagnostic and therapeutic procedures. Pediatrics 1992; 89: 1110-1115.

American Society of Anesthesiologists, House of Delegate Standards for basic intraoperative monitoring. American Society of Anesthesiologists’ 1992 Directory of Members. Park Ridge, Il. 1992; 675-676.

Baker KA, DeVor D. Safety considerations with high field MRI. Radiol Technol 1996; 67: 25-52.

Bassett CAL, Pilla AA, Pawluk RJ. A non-operative salvage of surgically-resistant pseudarthroses and non-unions by pulsing electromagnetic fields. Clin Orthop 1977; 124: 128.

Battocletti JH, Salles-Cunha S, Halbach RE, Nelson J, Sances Jr A., Antonich FJ. Exposure of rhesus monkeys to 20,000 G steady magnetic field: effect on blood parameters. Med Phys 1981; 8: 115-118.

Beischer DE. Human tolerance to magnetic fields. Astronautics 1962; 7: 24-48.

Bottomley PA, Edelstein WA. Power deposition in whole-body NMR imaging. Med Phys 1981; 8: 510-512.

Budinger TF. Nuclear magnetic resonance (NMR) in vivo studies: known thresholds for health effects. Comput Assist Tomogr. 1981; 5: 800-811 (review).

Budinger TF. Safety of NMR in vivo imaging and spectroscopy. in: Budinger TF, Margulis AR: Medical magnetic resonance imaging and spectroscopy. A primer. Society of Magnetic Resonance in Medicine: Berkeley, CA, U.S.A. 1986; 215-231 (review).

Budinger TF, Bird MD, Frydman L, Long JR, Mareci TH, Rooney WD, Rosen B, Schenck JF, Schepkin VD, Sherry AD, Sodickson DK, Springer CS, Thulborn KR, Uğurbil K, Wald LL. Toward 20 T magnetic resonance for human brain studies: opportunities for discovery and neuroscience rationale. MAGMA. 2016;29: 617-639 (review).

Budinger TF, Fischer H, Hentschel D, Reinfelder H-E, Schmitt F. Physiological effects of fast oscillating magnetic field gradients. J Comput Assist Tomogr 1991; 15: 909–914.

Cannie MM, De Keyzer F, Van Laere S, Leus A, de Mey J, Fourneau C, De Ridder F, Van Cauteren T, Willekens I, Jani JC. Potential heating effect in the gravid uterus by using 3-T MR imaging protocols: experimental study in miniature pigs. Radiology. 2016; 279: 754-761.

D’Arsonval MA. Action physiologique des courants alternatifs à grande fréquence. Arch d Physiol 1893; 5: 401-406.

D’Arsonval MA. Dispositifis pour la mesure des courants alternatifs à toutes fréquences. C R Soc Biol (Paris) 1896; 3: 451.

European Commission. Directive of the European Parliament and of the Council on the minimum health and safety requirements regarding the exposure of workers to the risks arising from physical agents (electromagnetic fields) (XXth individual Directive within the meaning of Article 16(1) of Directive 89/391/EEC). Brussels: European Commission, 2013. and: European Commission, Directorate-General, for Employment, Social Affairs and Inclusion, Unit B3. Non-binding guide to good practice for implementing Directive 2013/35/EU, Electromagnetic Fields, Volume 1: Practical Guide. Brussels: European Commission, 2015.

Faris OP, Shein M. Food and Drug Administration perspective: magnetic resonance imaging of pacemaker and implantable cardioverter-defibrillator patients. Circulation. 2006; 114: 1232–1233.

Foster JR, Hall DA, Summerfield AQ, Palmer AR, Bowtell RW. Sound-level measurements and calculations of safe noise dosage during EPI at 3 T. J Magn Reson Imaging. 2000;12: 157-163.

Fukunaga M, Li TQ, van Gelderen P, de Zwart JA, Shmueli K, Yao B, Lee J, Maric D, Aronova MA, Zhang G, Leapman RD, Schenck JF, Merkle H, Duyn JH. Layer-specific variation of iron content in cerebral cortex as a source of MRI contrast. Proc Natl Acad Sci U S A. 2010; 107: 3834-3839.

Gaffey CT, Tenforde TS. Alterations in the rat electrocardiogram induced by stationary magnetic fields. Bioelectromagnetics 1981; 2: 357-370.

Hentschel K, Goltz S, Ruppe I, Eggert S, Neuschulz H, Angerer M. Electrified railway transport systems, part 2: electric and magnetic fields emitted by conventional railway transport systems. Bundesanstalt für Arbeitsschutz und Arbeitsmedizin BAuA. Research Report Fb 800. Bremerhaven, Germany 1998.

Hepfner ST, Skelly MF. Radiofrequency interference in cochlear implants. N Engl J Med 1985; 313: 387.

Hong FT. Magnetic field effects on biomolecules, cells, and living organisms. Biosystems 1995; 36:187–229 (review).

Houpt TA, Cassell JA, Riccardi C, DenBleyker MD, Hood A, Smith JC. Rats avoid high magnetic fields: Dependence on an intact vestibular system. Physiology & Behavior 2007; 92: 741-747.

Hylton NM. Suspension of breast-feeding following gadopentetate dimeglumine administration. Radiology 2000; 216: 325-326.

ICNIRP, International Commission on Non-Ionizing Radiation Protection. Guidelines for limiting exposure to time-varying electric, magnetic. and electromagnetic fields (up to 300 GHz). Health Physics 1998; 74: 494-522. [Review]; and ICNIRP statement on the "Guidelines for limiting exposure to time-varying electric, magnetic, and electromagnetic fields (up to 300 GHz)." Health Physics 2009; 97: 257-258.

IEC, International Electrotechnical Commission. Medical electrical equipment - Part 2-33: Particular requirements for the basic safety and essential performance of magnetic resonance equipment for medical diagnosis. IEC 60601-2-33:2010+AMD1:2013+AMD2:2015. Geneva: IEC. 2016.

Kanal E, Shellock FG. Policies, guidelines, and recommendations for MR imaging safety and patient management. J Magn Reson Imaging 1992; 2: 247-248.

Kanal E, Gillen J, Evans J, Savitz D, Shellock FG. Survey of reproductive health among female MR workers. Radiology 1993; 187: 395-399.

Keltner JR, Roos MS, Brakeman PR, Budinger TF. Magnetohydrodynamics of blood flow. Magn Reson Med. 1990; 16: 139-149.

Kirschvink JL, Kobayashi-Kirschvink A, Diaz-Ricci JC, Kirschvink SJ. Magnetite in human tissues: a mechanism for the biological effects of weak ELF magnetic fields. Bioelectromagnetics 1992; Suppl 1: 101-113.

Landrø Svarliaunet AJ. Pasientkommunikasjon og gjennomføringsstrategi ved MR. Hold Pusten. 2014; 41: 24-28 (in Norwegian).

Led JJ, Petersen SB. Heating effects in carbon-13 NMR spectroscopy on aqueous solution caused by proton noise decoupling at high frequencies. J Mag Res 1978; 32: 1-17.

Levine GN, Gomes AS, Arai AE, Bluemke DA, Flamm SD, Kanal E, Manning WJ, Martin ET, Smith JM, Wilke N, Shellock FG. Safety of magnetic resonance imaging in patients with cardiovascular devices: an American Heart Association scientific statement from the Committee on Diagnostic and Interventional Cardiac Catheterization. Circulation. 2007; 116: 2878-2891.

Liboff RL. A biomagnetic hypothesis. Biophys J 1965; 5: 845.

Magin RL, Liburdy RP, Persson B. Biological effects and safety aspects of nuclear magnetic resonance imaging and spectroscopy. Annals of the New York Academy of Sciences; vol. 649, 31 March 1992.

Mansfield P, Haywood B. Principles of active acoustic control in gradient coil design. Magn Reson Materials Phys Biol Med 2000; 10: 147-151.

Mansfield P, Morris PG. NMR imaging in medicine. Biomagnetic effects. New York, London: Academic Press. 1981, 297-332.

Mark AS, Hricak H. Intrauterine contraceptive devices: MR imaging. Radiology 1987; 162: 311-314.

Medical Advisory Secretariat. Patient monitoring system for MRI: an evidence based analysis. Ontario Health Technology Assessment Series. Toronto, Ontario; Canada 2003; 3 (7).

Milham S. Mortality from leukemia in workers exposed to electrical and magnetic fields. N Engl J Med 1982; 307: 249.

Mollerus M, Albin G, Lipinski M, Lucca J. Magnetic resonance imaging of pacemakers and implantable cardioverter-defibrillators without specific absorption rate restrictions. Europace 2010; 12: 947-951

NEMA Standards Publication MS 8-2008. Characterization of the Specific Absorption Rate for Magnetic Resonance Imaging Systems. www.nema.org.

Nitz WR, Brinker G, Diehl D, Frese G. Specific absorption rate as a poor indicator of magnetic resonance-related implant heating. Invest Radiol 2005; 40: 773-776.

Persson BRR, Ståhlberg F. Safety Aspects of Magnetic Resonance Examinations. International Journal of Technology Assessment in Health Care. 1985; 1: 647-665 (review).

Radiological Health, Bureau of (United States of America). Guidelines for evaluating electromagnetic risk for trials of clinical NMR systems. Department of Health and Human Services, Public Health Service, Food and Drug Adminstration. Rockville, 25 February 1982; and: US Food and Drug Administration: Magnetic resonance diagnostic device; panel recommendation and report on petitions for MR reclassification. Fed Reg 1988; 53: 7575-7579.

Radiological Protection Board, National (United Kingdom). Exposure to nuclear magnetic resonance clinical imaging. Radiography 1981;47:258-260.

Radiological Protection Board, National (United Kingdom). Electromagnetic fields and the risk of cancer. Documents of the NRPB 3, 1 Didcot, Oxon: NRPB. 1992.

Radomskij P, Schmidt MA, Heron CW, Prasher D. Effect of MRI noise on cochlear function. Lancet 2002; 359: 1485.

Rinck PA. Risiken und Gefahren der NMR-Tomographie; Vorschläge zum Schutz und zur Überwachung (Risks and hazards in MR imaging; proposals for protection and surveillance). Dtsch Med Wschr 1983; 108: 992-994 (review).

Rivi D (Food and Drug Administration of the United States of America - FDA). Magnetic resonance imaging (MRI) safety. Introduction to public workshop. FDA/Center for Devices and Radiological Health/Office of Surveillance and Biometrics. Washington, DC. 25 October 2011. www. fda.gov/downloads/MedicalDevices/NewsEvents/ WorkshopsConferences/ UCM284019.pdf

Roberts DC, Marcelli V, Gillen JS, Carey JP, Della Santina CC, Zee DS. MRI magnetic field stimulates rotational sensors of the brain. Curr Biol 2011; 21: 1635-1640.

Roguin A, Schwitter J, Vahlhaus C, Lombardi M, Brugada J, Vardas P et al. Magnetic resonance imaging in individuals with cardiovascular implantable electronic devices. Europace 2008; 10: 336-346.

Schaap K. Working with MRI: An investigation of occupational exposure to strong static magnetic fields and associated symptoms. Thesis, Utrecht University. 2015.

Schenck JF, Dumoulin CL, Redington RW, Kressel HY, Elliott RT, McDougall IL. Human exposure to 4.0-Tesla magnetic fields in a whole-body scanner. Med Phys. 1992; 19: 1089-1098.

Schröder P-M, Miksicek A, Koralewski H-E, Römer T. Kernspin-Tomographie bei Patienten mit Nervenschrittmachern (English abstract: MR in Patients with nerve pacemakers). Fortschr Röntgenstr 1987; 147: 198-199.

Schultheiss-Grassi PP, Wessiken R, Dobson J. TEM investigations of biogenic magnetite extracted from the human hippocampus. Biochim Biophys Acta. 1999; 1426: 212-216.

Schwartz JL, Crooks LE. NMR imaging produces no observable mutations or cytotoxicity in mammalian cells. AJR 1982; 139: 583-585.

Shellock FG, Kanal E. Magnetic resonance: bioeffects, safety, and patient management. Philadelphia, PA, U.S.A.: Lippincott-Raven 1994.

Shellock FG, Crues III JV. MR procedures: biologic effects, safety, and patient care. Radiology 2004; 232: 635-652.

Shellock FG, Woods TO, Crues III JV. MR labeling information for implants and devices: explanation of terminology. Radiology 2009; 253: 26-30.

Soulen RL, Budinger TF, Higgins CB. Magnetic resonance imaging of prosthetic heart valves. Radiology 1985; 154: 705-707.

Tenforde TS, Gaffey CT, Moyer BR, Budinger TF. Cardiovascular alterations in Macaca monkeys exposed to stationary magnetic fields: experimental observations and theoretical analysis. Bioelectromagnetics 1983; 4: 1.

Thormann M, Amthauer H, Adolf D, Wollrab A, Ricke J, Speck O. Efficacy of diphenhydramine in the prevention of vertigo and nausea at 7 T MRI. Eur J Radiol. 2013; 82: 768-772.

U.S. Department of Health and Human Services; Food and Drug Administration; Center for Devices and Radiological HealthRadiological Devices Branch; Division of Reproductive, Abdominal, and Radiological Devices; Office of Device Evaluation. Guidance for Industryand FDA Staff Criteria for Significant Risk; Investigations of Magnetic Resonance Diagnostic Devices; Document issued on: July 14, 2003.

van Nierop LE. The magnetized brain. Working mechanisms for the effect of MRI-related magnetic fields on cognition, postural stability, and oculomotor function. Thesis, Utrecht University. 2015.

Vijayalaxmi FM, Speck O. Magnetic resonance imaging (MRI): a review of genetic damage investigations. Mutat Res 2015; 764: 51–63 (review).

Wertheimer N, Leeper E. Electric wiring configurations and childhood cancer. Am J Epidemiol 1979; 109: 273-284.

Wikswo JP, Barach JP. An estimate of the steady magnetic field strength required to influence nerve conduction. IEEE Trans Biomed Eng 1980; 27: 722–723.

Zhang, Yong-shang, Heng-wang, Wu. Der Einfluß von magnetisiertem Wasser auf Harnstein. Eine experimentelle und klinische Studie. Acta Acad Med Wuhan 1984; 4: 31-37.


第19章

No references


spaceholder 600 spaceholder 600

LogoTop
LogoBottom
space
00-f1
space
00-f2
space
00-f3
space
00-f4
space
00-f7
space
00-f1
space
00-f2
space
00-f3
space
00-f4
space
00-f7
space
00-f1
space
00-f2
space
00-f3
space
00-f4
space
00-f7
space
00-f1
space
00-f2
space
00-f3
space
00-f4
space
00-f7
space
00-f1
space
00-f2
space
00-f3